altimmune.com Open in urlscan Pro
2001:19f0:5:3d77:5400:4ff:fe90:9b9c  Public Scan

Submitted URL: http://altimmune.com/
Effective URL: https://altimmune.com/
Submission: On September 21 via manual from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

Skip to main content
Menu
 * ABOUT US
   * COMPANY OVERVIEW
   * EXECUTIVE TEAM
   * SENIOR LEADERSHIP TEAM
   * BOARD OF DIRECTORS
   * SCIENTIFIC ADVISORY BOARDS
   * PARTNERSHIPS
 * PIPELINE
   * OUR PIPELINE
   * Pemvidutide
   * HepTcell™
 * INVESTORS
   * OVERVIEW
   * PRESS RELEASES
     * PRESS RELEASES
     * PHARMATHENE, INC. HISTORICAL PRESS RELEASES
   * IN THE NEWS
   * EVENTS AND PRESENTATIONS
   * STOCK INFORMATION
     * STOCK QUOTE & CHART
     * HISTORICAL PRICE LOOKUP
     * INVESTMENT CALCULATOR
   * ANALYST COVERAGE
   * GOVERNANCE
     * DOCUMENTS & CHARTERS
     * MANAGEMENT TEAM
     * BOARD OF DIRECTORS
     * COMMITTEE COMPOSITION
   * FINANCIALS
     * SEC FILINGS
   * INVESTOR RESOURCES
     * INVESTOR FAQS
     * IR CONTACT
     * EMAIL ALERTS
 * CLINICAL TRIALS
 * JOIN TRIAL
 * CAREERS
 * CONTACT US



JOIN OUR MOMENTUM TRIAL


OUR FOCUS

DEVELOPING NEXT GENERATION PEPTIDE THERAPEUTICS FOR OBESITY AND LIVER DISEASE


OUR PROGRAMS

We are a clinical stage biopharmaceutical company developing peptide-based
therapeutics:

 * Pemvidutide for obesity
 * Pemvidutide for non-alcoholic steatohepatitis (NASH)
 * HepTcell™ for chronic hepatitis B

VIEW PIPELINE


910 Clopper Road
Suite 201-S
Gaithersburg, MD 20878
(240) 654-1450

ALTIMMUNE

 * About Us
 * Pipeline
 * Clinical Trials
 * Partnerships
 * Careers
 * Contact Us
 * Terms & Conditions
 * Privacy Policy

PIPELINE

 * Our Pipeline
 * Pemvidutide
 * HepTcell™

INVESTORS

 * Overview
 * Press Releases
 * In The News
 * Events & Presentations
 * Stock Information
 * Analyst Coverage
 * Governance
 * Financials
 * Investor Resources

© 2023 Altimmune Website. All rights reserved.

 * LinkedIn

 * ABOUT US
   * COMPANY OVERVIEW
   * EXECUTIVE TEAM
   * SENIOR LEADERSHIP TEAM
   * BOARD OF DIRECTORS
   * SCIENTIFIC ADVISORY BOARDS
   * PARTNERSHIPS
 * PIPELINE
   * OUR PIPELINE
   * Pemvidutide
   * HepTcell™
 * INVESTORS
   * OVERVIEW
   * PRESS RELEASES
     * PRESS RELEASES
     * PHARMATHENE, INC. HISTORICAL PRESS RELEASES
   * IN THE NEWS
   * EVENTS AND PRESENTATIONS
   * STOCK INFORMATION
     * STOCK QUOTE & CHART
     * HISTORICAL PRICE LOOKUP
     * INVESTMENT CALCULATOR
   * ANALYST COVERAGE
   * GOVERNANCE
     * DOCUMENTS & CHARTERS
     * MANAGEMENT TEAM
     * BOARD OF DIRECTORS
     * COMMITTEE COMPOSITION
   * FINANCIALS
     * SEC FILINGS
   * INVESTOR RESOURCES
     * INVESTOR FAQS
     * IR CONTACT
     * EMAIL ALERTS
 * CLINICAL TRIALS
 * JOIN TRIAL
 * CAREERS
 * CONTACT US



Close Menu